Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk
Several genetic mutations previously linked to breast cancer and included on commercial genetic tests, including direct-to-consumer tests, were found not to increase a woman’s risk of disease, according to a population study of more than 64,000 women published online on January 20, 2021 in the New England Journal of Medicine from several institutions, including Penn Medicine. The findings show that risks associated with mutations for women in the general population are often lower than previous estimates, and, importantly, provide new insights informing the debate over whom should be recommended for genetic testing.
Penn Medicine authors on the paper—which analyzed data from the CARRIERS study, or “CAnceR RIsk Estimates Related to Susceptibility”—include Katherine L. Nathanson, deputy director of the Abramson Cancer Center and the Pearl Basser Professor for BRCA-Related Research in the Perelman School of Medicine at the University of Pennsylvania, and Susan M. Domchek, executive director of the Basser Center for BRCA at the Abramson Cancer Center. Fergus J. Couch, of the Mayo Clinic, was the paper’s senior author.
According to past estimates, seven to ten percent of women with breast cancer carry pathogenic variants in genes associated with an increased risk. However, that statistic is based largely on studies of high-risk women, including those with a family history or a young age at the time of their cancer diagnosis.
This study—the first to look at a large group of women of different ages from the general population—suggests that the frequency of pathogenic variants in genes associated with breast cancer risk among women in the general population is five percent. Further, of the 28 breast cancer genes studied, only 12 had clear evidence of associated cancer risk.
Recommendations for genetic screening vary, from testing all patients for genes associated with breast cancer to testing affected and unaffected women based on risk stratification. Many commercially available hereditary genetic tests also include a slew of genes that now appear, based off these findings, to not increase risk, which has the potential to lead to the delivery of misinformation, as well as affect treatment decisions.
“This multi-institutional, collaborative study shows us a clearer picture of risk and genetic drivers for women in the general population who don’t fall under the high-risk category,” Dr. Domchek said. “As discussions continue regarding the role of population screening, the CARRIERS data support careful gene selection.”
For more information, visit https://tinyurl.com/BCmutations
"breast" - Google News
February 02, 2021 at 12:25PM
https://ift.tt/2MjA58S
Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk - UPENN Almanac
"breast" - Google News
https://ift.tt/2ImtPYC
https://ift.tt/2Wle22m
Bagikan Berita Ini
0 Response to "Mutations Commonly Linked to Breast Cancer Found to Pose No Increased Risk - UPENN Almanac"
Post a Comment